"US managed care plans have capricious coverage policies"
This article was originally published in Clinica
Researchers from the California think-tank RAND briefed members of the US Health Industry Manufacturers Association at the group's annual meeting in Phoenix, Arizona, last month on the results of a new study on how managed care plans decide whether or not to cover new technology. Most do not systematically research promising new products, but instead react to physician and patient demands, prior-authorisation requests and claims submitted without a code, they said.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.